Skip to main navigation
Skip to search
Skip to main content
Aston Research Explorer Home
Help & FAQ
Home
Research units
Profiles
Research Outputs
Datasets
Student theses
Activities
Press/Media
Prizes
Equipment
Search by expertise, name or affiliation
Pharmacotherapies to manage diabesity: an update
Caroline Day,
Clifford J. Bailey
School of Biosciences
Aston Research Centre for Health in Ageing
College of Health and Life Sciences
Cell & Tissue Biomedical Research
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacotherapies to manage diabesity: an update'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Hypoglycemia
100%
Liraglutide
96%
Weight Loss
85%
Metformin
74%
Glucose
65%
Hyperglycemia
62%
rGLP-1 protein
62%
Drug Therapy
60%
dulaglutide
59%
lixisenatide
58%
alogliptin
57%
insulin degludec
57%
saxagliptin
55%
Linagliptin
55%
Canagliflozin
54%
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
53%
empagliflozin
53%
Vildagliptin
53%
Sitagliptin Phosphate
49%
Exenatide
46%
Dipeptidyl-Peptidase IV Inhibitors
45%
Incretins
44%
Glucagon-Like Peptide-1 Receptor
44%
Glucagon-Like Peptide 1
40%
Gastric Emptying
39%
Glucagon
35%
Complementary Therapies
35%
Insulin Secretion
34%
Weight Gain
31%
Meals
30%
Half-Life
30%
Nausea
30%
Life Style
28%
Type 2 Diabetes Mellitus
25%
Urine
24%
Obesity
24%
Kidney
18%